Reply: Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndrome

Int J Cardiol. 2018 Aug 15:265:236. doi: 10.1016/j.ijcard.2018.04.056.

Authors

Po-Min Chen¹, Mikiko Ohno², Takeshi Kimura¹, Eiichiro Nishi³

Affiliations

¹ Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
² Department of Pharmacology, Shiga University of Medical Science, Otsu, Japan.
³ Department of Pharmacology, Shiga University of Medical Science, Otsu, Japan. Electronic address: [email protected].

PMID: 29885690
DOI: 10.1016/j.ijcard.2018.04.056

No abstract available

Keywords: Biomarker; Unstable angina.

Publication types

Letter
Comment

MeSH terms

Acute Coronary Syndrome*
Biomarkers
Early Diagnosis
Humans
Metalloendopeptidases*
Myocardial Infarction

Substances

Biomarkers
Metalloendopeptidases
nardilysin